Press

Featured

In Ireland, WuXi NextCODE Embarks on Unprecedented Effort to Enable Precision Medicine at National Scale, with Global Impact

Centerpiece of this effort is the acquisition of Genomics Medicine Ireland (GMI) as WXNC's Irish subsidiary, part of $400m in Ireland precision medicine investments announced today.

See Details

Filter Year:

November 27, 2018

WuXi NextCODE Completes $200 Million Series C Financing

Leading global sovereign and technology investors from Ireland, Singapore, US and China back its data strategy to expand the reach and power of the leading global platform in genomics. Major investments in Ireland aim to create the world's premier genomic and medical dataset, uniquely powered to accelerate drug discovery and deliver meaningful benefits of precision medicine to global patients.

Read More
September 24, 2018

WuXi NextCODE named in Fast Company’s Top 10 Most Innovative Companies in Biotech 2018

Read More
September 19, 2018

WuXi NextCODE Unveils Genomics Partnership with Google Cloud

Read More
April 26, 2018

Introducing an Internet of DNA for Solving Rare Disease

At the World Orphan Drug Congress on April 26, WuXi NextCODE presents novel global strategy to accelerate diagnosis and better treatments to improve the lives of patients worldwide.

Read More
April 15, 2018

GRAIL and Amgen Veteran Richard Williams to Lead Cancer Genomics Business

At AACR, Williams and colleagues will showcase the company's portfolio of cutting edge capabilities for using genomic data to optimize and advance cancer therapies

Read More
March 12, 2018

WuXi NextCODE Announces Executive Leadership Transition

Read More
January 18, 2018

WuXi NextCODE Appoints Accomplished Life Sciences Senior Executive Louis Yuan as China General Manager

Read More
January 9, 2018

AI Advances Precision Therapy for Rare Genetic Disorders of Obesity

Read More
November 9, 2017

We’ve Appointed Baidu Veteran John Gu

Read More
October 18, 2017

We are at ASHG 2017

Read More
October 17, 2017

Integrating Oxford Nanopore into Our Platform

Read More